As per the report, the North America Portable Oxygen Concentrators Market size was worth USD 0.70 billion in 2024. It is further expected to grow at a CAGR of 7.7% and value USD 1.01 billion by 2029 during the forecast period 2024 to 2029.
The growing frequency of respiratory disorders, rapid expansion in the geriatric population, high prevalence of cigarette smoking, desire for home-based oxygen therapy, and technical improvements drive the North American portable oxygen concentrators market. Factors driving the market's growth are the rising frequency of respiratory disorders like sleep apnea and asthma.
Various product advancements, such as the development of variations with increased battery life and smaller membrane technologies, improvements in healthcare infrastructure, and intensive research and development (R & R&D) activities, are also helping to propel the industry forward. The market for oxygen concentrators is predicted to develop due to an increase in demand for medical oxygen and various oxygen therapy devices to treat COVID-19 patients. The portable oxygen concentrators market supports the patient's lifestyle.
Continuous research and development are carried out to introduce products that allow patients to live a meaningful lifestyle. It helps to accelerate the growth of the portable oxygen concentrators market. The United States has the fastest-growing senior population, with COPD being the fourth leading cause of death. The North American mobile oxygen concentrators market is growing due to changing lifestyles and alarming smokers.
Local manufacturers' low-cost alternatives, strict regulatory rules causing delays in product approvals, and Medicare reimbursement rate decreases for home oxygen therapy are all restricting the market's growth to some extent. In addition, the risk of respiratory infections resulting from filthy and polluted equipment and adverse side effects such as skin irritation may serve to restrict market expansion.
Geographically, the healthcare systems in the United States and Canada are well-developed and regimented. These platforms also encourage research and development. These policies encourage international companies to invest in the United States and Canada. The market is likely to grow further as global companies match high demand in the region.
The COVID-19 pandemic's unexpected emergence has raised the need for respiratory care goods. COVID-19 has several side effects: low blood oxygen levels, which necessitate oxygen support for patients to recover. Under the Emergency Use Authorization program, the US Food and Drug Administration has also approved the use of O2 generators. As a result, market growth is projected. Respiratory disorders such as asthma, COPD, fibrosis, and pulmonary hypertension are more common in the elderly population, expected to increase the market growth. According to the United Nations Department of Economic and Social Affairs, Northern America has a large population of elderly individuals.
Some of the promising companies leading the North America Portable Oxygen Concentrators Market profiled in the report are Koninklijke Philips N.V., Inogen Inc., Chart Industries Inc., Resmed Inc., Invacare Corporation, Drive DeVilbiss Healthcare, Precision Medical Inc., Foshan Keyhub Electronic Industries Co. Ltd., O2 Concepts LLC, and GCE Group.,
Related Reports
Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2000
Didn’t find what you’re looking for?
TALK TO OUR ANALYST TEAM
Need something within your budget?
NO WORRIES! WE GOT YOU COVERED!
Call us on: +1 888 702 9696 (U.S Toll Free)
Write to us: [email protected]
Reports By Region